iifl-logo

Piramal Pharma Ltd Historical Data

211.03
(2.28%)
Jun 9, 2025|12:00:00 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Piramal Pharma Ltd Historical Data

10/05/2025calendar-icon
10/06/2025calendar-icon
Date
Open(₹)
High(₹)
Low(₹)
Close(₹)
No. Of Trades(₹)
Total Turnover(₹)
Deliverable Quantity(₹)

12-May-2025

210.59

213.87207.221256,8541,19,00,02,375.7821,03,206

13-May-2025

215

221.25213.75214.8451,0281,24,70,34,266.0717,65,393

14-May-2025

215.87

220214.22219.0431,26677,05,52,494.2614,01,254

15-May-2025

223.3

226207.95208.611,15,4623,06,70,38,317.9970,16,468

16-May-2025

210

210.5204.44204.8775,9661,48,38,02,642.3740,18,302

19-May-2025

207

210.05204.66205.4359,7941,02,25,36,978.1222,61,649

20-May-2025

206.15

207.37202205.7852,76670,94,56,379.4716,79,332

21-May-2025

206.4

208.28204.7206.1523,84449,83,87,300.758,58,954

22-May-2025

206.15

207.49204.6206.3218,66434,39,85,653.686,29,720

23-May-2025

200.5

206.2200.5205.3327,84171,84,44,088.8722,23,565

26-May-2025

206.7

208.2204.75205.2722,66148,05,04,670.919,91,989

27-May-2025

205.2

206.4202.05203.3329,48760,85,52,845.3516,13,672

28-May-2025

204.49

206.81202.4202.8839,25971,44,70,690.6319,37,685

29-May-2025

203.99

206.3202.9205.0939,21092,47,83,101.7929,41,206

30-May-2025

206

209.7205.5206.344,7951,23,94,32,100.1528,05,068

02-Jun-2025

207.4

209.4205.1205.6843,76676,94,33,895.6715,99,339

03-Jun-2025

205.68

206.69203.2203.7617,55237,41,73,985.269,05,563

04-Jun-2025

204.49

206.55201.51205.9426,98764,13,44,470.2714,84,654

05-Jun-2025

206.8

210.28204.61208.0833,9601,09,00,88,654.2920,87,222

06-Jun-2025

208.08

209.5205.8206.3324,43060,84,57,588.4711,86,444

09-Jun-2025

208.75

213.65207.85211.0345,4801,63,83,16,750.2137,05,513

Piramal Pharma: Related NEWS

Piramal Pharma’s Canada unit gets NAI from USFDA
2 Jun 2025|03:18 PM

The company stated in its filing with the bourses that its remains committed to maintain highest compliance standards.

Read More
Piramal Pharma unit gets approval to market Neoatricon in UK
21 Mar 2025|11:14 AM

Piramal Critical Care has reserved commercialisation rights for the EU, UK, and Norway and will look after Neoatricon in these regions.

Read More
Piramal Pharma’s Turbhe Facility Gets US FDA Observations
18 Feb 2025|11:02 PM

This month, the US FDA inspected the facility and after inspection issued a Form 483 of six observations as the company has to improve compliance in this regard.

Read More
Piramal Pharma Q3 Profit Drops 63% YoY, Revenue Up 12.5%
29 Jan 2025|11:11 PM

In response to growing demand of IA, capacity expansions are under way at both Dahej and Digwal facilities, with month-on-month production growth.

Read More
Piramal Pharma Launches Chlorpromazine Injection in US Market
23 Jan 2025|12:06 PM

As part of long-term strategy PCC has seen a number of product launches during recent times which are building block towards market presence in generic injectables.

Read More
Piramal Enterprises Invests ₹1,000 Crore in Subsidiary PCHFL for Growth
31 Dec 2024|09:48 PM

The transaction falls in the internal transaction category because the parent is trading with a subsidiary.

Read More
Piramal Pharma Invests $85M to Fuel Growth, Eyes $2B Revenue by FY30
27 Oct 2024|05:05 PM

Piramal Pharma Solutions (PPS) is set to invest $80 million in expanding its sterile injectables facility in Lexington, Kentucky, USA, projected for completion by FY27.

Read More
Piramal Pharma logs 350% y-o-y growth in Q2 net profit
24 Oct 2024|02:30 PM

Piramal Pharma Limited's Chairperson, Nandini Piramal, attributed the company's development to its solid operational performance.

Read More
Piramal Pharma Ahmedabad facility gets EIR from USFDA
30 Sep 2024|07:48 PM

On September 11, 2024, and October 26, 2023, the stock reached a 52-week high of ₹244.10 and a low of ₹87.55.

Read More
Top 10 stocks for today – 15th July, 2024
15 Jul 2024|08:59 AM

Here are some of the stocks that may see significant price movement today: HCL Technologies, Lupin, Piramal Pharma, etc.

Read More

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Knowledge Center
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Capital Services Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Loading...

Follow us on

facebooktwitterrssyoutubeinstagramlinkedintelegram

2025, IIFL Capital Services Ltd. All Rights Reserved

ATTENTION INVESTORS

RISK DISCLOSURE ON DERIVATIVES

Copyright © IIFL Capital Services Limited (Formerly known as IIFL Securities Ltd). All rights Reserved.

IIFL Capital Services Limited - Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248
ARN NO : 47791 (AMFI Registered Mutual Fund Distributor)

ISO certification icon
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.